🦬Montana State AG
Clustered 4 filings across 3 jurisdictions · filed Jul 10, 2023. View entity profile → Other incidents for this victim →
incident inc_448deeb5ce37448f · merge_method deterministic · confidence 100%
Discovered → first regulatory filing
Range of discovered_at dates across filings
CA ME MT
Time between earliest and latest filing
Not recorded for this incident
Leak precedence · Materiality delta · SEC filing delay — no leak-site claim in this cluster; no SEC 8-K in this cluster.
all State AG
per-filing reported counts
State AGs report only their own residents; bars show per-filing counts.
Earliest sighting first · deep chronology in Litigation Timeline
Mar 15, 2023
When the intrusion reportedly occurred, per the linked filings
Apr 9, 2023
Reported by MAINE AG, CALIFORNIA AG filings
About this clustering
DisclosureLens links filings into incidents through layered matchers: deterministic rules (same source document, multistate filings of one breach, tight-window same-victim pairs), a weighted-similarity scorer for cross-source candidates, and an operator review queue for everything uncertain. Each link records its own method and confidence — shown per filing in the timeline below. The system defaults to NOT merging when uncertain, because a false merge (collapsing two unrelated breaches) is more harmful than a false split (showing related filings separately); uncertain pairs route to human review instead of auto-merging. Filing summaries shown in the timeline are AI-generated extracts — verify each against its linked source.
Revance Therapeutics, Inc reported a data breach to the Montana Attorney General. The breach was reported on 2023-07-10. The breach occurred from 3/15/2023 to 4/10/2023. 2 Montana residents were affected.
Affected (this filing): 2
On April 9, 2023, Revance Therapeutics, Inc. discovered that an unauthorized third party had accessed its systems between March 15, 2023, and April 10, 2023, by compromising an employee's credentials. The investigation, completed on June 15, 2023, confirmed that personal information, including financial account details, was exfiltrated. The company has since enhanced its security controls, notified law enforcement, and offered 24 months of identity monitoring services to affected individuals.
Affected (this filing): 1
Revance Therapeutics, Inc. reported a data breach affecting 2,803 individuals after an unauthorized third party accessed company systems using compromised employee credentials between March 15, 2023, and April 10, 2023. The breach was discovered on April 9, 2023. The compromised information included names and financial account numbers with access codes. In response, Revance engaged a cybersecurity firm, notified law enforcement, and offered 24 months of identity monitoring services to affected individuals. The company has since enhanced its identity access and authentication controls.
Affected (this filing): 2,803
Revance Therapeutics, Inc. disclosed that an unauthorized third party accessed and exfiltrated personal information from its systems between March 15, 2023, and April 10, 2023. The company discovered the incident on April 9, 2023. Affected data includes names and other personal information. Revance terminated the attacker's access, engaged cybersecurity specialists, notified law enforcement, and offered two years of identity monitoring through Kroll.